AMRYT PHARMA PLC— a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases have raised $60m before expenses and will relist on the AIM Market on the 25/09/2019
11 Sep 2019
Small Cap Feast
Sigmaroc, 37.0 | Science In Sport, 35.0 | 88 Energy, 0.3 | Charles Taylor, 0 | Eco Animal Health Group, 207 | Armadale Capital, 3.9 | KRM22, 31.5 | Riverfort Global Opportunities, 0.8 | Conroy Gold And Natural Resources, 11.0 | Altyn, 1.5
-
-
-
Derren Nathan
-
.png)
